Associations between Serum High-Density Lipoprotein Cholesterol or Apolipoprotein AI Levels and Common Genetic Variants of the ABCA1 Gene in Japanese School-aged Children

Metabolism: Clinical and Experimental

Volumn 53, Issue 2, 2004, Pages 182-186

  Yamakawa Kobayashi, Kimiko ^a   Yanagi, Hisako ^b   Yu, YuXing ^b   Endo, Kazue ^b   Arinami, Tadao ^b   Hamaguchi, Hideo ^b  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; UNCLASSIFIED DRUG;

ABCA1 GENE; ADOLESCENT; ALLELE; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; DNA FLANKING REGION; DNA POLYMORPHISM; FEMALE; GENE; GENE ACTIVITY; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC VARIABILITY; HUMAN; HYPOALPHALIPOPROTEINEMIA; HYPOLIPOPROTEINEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0842284600     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2003.08.009     Document Type: Article

References (32)

1. Gordon T, Castelli WP, Hjortland MC, et al: High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study. Am J Med 62:707-714, 1977
2. Castelli WP, Garrison RJ, Wilson PW, et al: Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Study. JAMA 256:2835-2838, 1986
3. Gordon DJ, Rifkind BM: High-density lipoprotein: The clinical implications of recent studies. N Engl J Med 321:1311-1316, 1989
4. Tall AR, Breslow JL, Rubin EM: Genetic disorders affecting plasma high-density lipoproteins, in Scriver CR, Beaudet AL, Sly WS, et al (eds): The metabolic and Molecular Basis of Inherited Disease (ed 8). vol 2. New York, NY, McGraw Hill, 2002. pp 2915-2936
5. Gylling H, Vega GL, Grundy SM: Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids. J Lipid Res 33:1527-1539, 1992
6. Glomset JA, Norum KR: The metabolic role of lecithin:cholesterol acyltransferase: Perspectives form pathology. Adv Lipid Res 11:1-65, 1973
7. Fielding CJ, Fielding PE: Molecular physiology of reverse cholesterol transport. J Lipid Res 36:211-228, 1995
8. Oram JF, Vaughan AM: ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins. Curr Opin Lipidol 11:253-260, 2000
9. Attie AD, Kastelein JP, Hayden MR: Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis. J Lipid Res 42:1717-1726, 2001
10. Brooks-Wilson A, Marcil M, Clee SM, et al: Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 22:336-345, 1999
11. Bodzioch M, Orso E, Klucken J, et al: The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22:347-351, 1999
12. Rust S, Rosier M, Funke H, et al: Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 22:352-355, 1999
13. Marcil M, Brooks-Wilson A, Clee SM, et al: Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet 354:1341-1346, 1999
14. Mott S, Yu L, Marcil M, et al: Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations. Atherosclerosis 152:457-468, 2000
15. Wang J, Burnett JR, Near S, et al: Common and rare ABCA1 variants affecting plasma HDL cholesterol. Arterioscler Thromb Vasc Biol 20:1983-1989, 2000
16. Clee SM, Zwinderman AH, Engert JC, et al: Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 103:1198-1205, 2001
17. Lutucuta S, Ballantyne CM, Elghannam H, et al: Novel polymorphisms in promoter region of ATP binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ Res 88:969-973, 2001
18. Zwarts KY, Clee SM, Zwinderman AH, et al: ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels. Clin Genet 61:115-125, 2002
19. Takagi S, Iwai N, Miyazaki S, et al: Relationship between ABCA1 genetic variation and HDL cholesterol level in subjects with ischemic heart diseases in Japanese. Thromb Haemast 88:369-370, 2002
20. Ikeda T, Shibuya Y, Senba U, et al: Automated immunoturbidimetric analysis of six plasma apolipoproteins: Correlation with radial immunodiffusion assays. J Clin Lab Anal 5:90-95, 1991
21. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
22. Pullinger CR, Hakamata H, Duchateau PN, et al: Analysis of hABC1 gene 5′ end: Additional peptide sequence, promoter region, and four polymorphisms. Biochem Biophys Res Commun 271:451-455, 2000
23. Iida A, Saito S, Sekine A, et al: High-density single-nucleotide polymorphism (SNP) map of the 150-kb region corresponding to the human ATP-binding cassette transporter A1 (ABCA1) gene. J Hum Genet 46:522-528, 2001
24. Cenarro A, Artieda M, Castillo S, et al: A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia. J Med Genet 40:163-168, 2003
25. Evans D, Beil FU: The association of the R219K polymorphism in the ATP-binding cassette transporter 1 (ABCA1) gene with coronary heart disease and hyperlipidaemia. J Mol Med 81:264-270, 2003
26. Assmann G, von Eckardstein A, Brewer HB Jr: Familial analphalipoproteinemia: Tangier disease, in Scriver CR, Beaudet AL, Sly WS et al, (eds): The Metabolic and Molecular Basis of Inherited Disease (ed 8), vol 2. New York, NY, McGraw Hill, 2002, pp 2937-2960
27. McNeish J, Aiello RJ, Guyot D, et al: High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc Natl Acad Sci USA 97:4245-4250, 2000
28. Haghpassand M, Bourassa PA, Francone OL, et al: Monocyte/ macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J Clin Invest 108:1315-1320, 2001
29. van Eck M, Bos IS, Kaminski WE, et al: Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc Natl Acad Sci USA 99:6298-6303, 2002
30. Aiello RJ, Brees D, Bourassa PA, et al: Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler Thromb Vasc Biol 22:630-637, 2002
31. Tell GS, Mittelmark MB, Vellar OD: Cholesterol, high density lipoprotein cholesterol and triglycerides during puberty: The Oslo Youth Study. Am J Epidemiol 122:750-761, 1985
32. Bertrais S, Balkau B, Charles MA, et al: Puberty-associated differences in total cholesterol and triglyceride levels according to sex in French children aged 10-13 years. Ann Epidemiol 10:316-323, 2000